Zhejiang Hisoar Pharmaceutical

Taizhou, China Founded: 1966 • Age: 60 yrs
Speciality raw materials, fine chemicals, and dye intermediates are manufactured.
Annual revenue $261.7M Latest available
Total funding - Funding intelligence
Employees 2610 Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors - Brand Intelligence

About Zhejiang Hisoar Pharmaceutical

Zhejiang Hisoar Pharmaceutical is a company based in Taizhou (China) founded in 1966. The company has 2,610 employees as of December 31, 2024.

  • Headquarter Taizhou, China
  • Employees 2610 as on 31 Dec, 2024
  • Stage Public
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Zhejiang Hisoar Pharmaceutical Co., Ltd. Class A
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $261.67 M (USD)
    -10.94
    as on Dec 31, 2024
  • Net Profit
    -$45.25 M (USD)
    21.38
    as on Dec 31, 2024
  • EBITDA
    $27.71 M (USD)
    127.57
    as on Dec 31, 2024
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    2610

    as on Dec 31, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Zhejiang Hisoar Pharmaceutical

Zhejiang Hisoar Pharmaceutical is a publicly listed company on the SZSE with ticker symbol 002099 in China, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: SZSE · Ticker: 002099 · Sector: Health technology · China

Funding Insights of Zhejiang Hisoar Pharmaceutical

Premium access

Detailed funding history for Zhejiang Hisoar Pharmaceutical

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Zhejiang Hisoar Pharmaceutical

Investments
Premium access

Investment portfolio details for Zhejiang Hisoar Pharmaceutical

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Zhejiang Hisoar Pharmaceutical

Premium access

Detailed financials for Zhejiang Hisoar Pharmaceutical

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Zhejiang Hisoar Pharmaceutical Comparisons

Zhejiang Hisoar Pharmaceutical Primary company
Description
Speciality raw materials, fine chemicals, and dye intermedia...
Location
Taizhou, China
Founded Year
1966
Annual Revenue
$261.67 M (USD)
Net Profit
-$45.25 M (USD)
EBITDA
$27.71 M (USD)
Employees
2,610
As of 2024
Premium access

Peer comparison for Zhejiang Hisoar Pharmaceutical

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Zhejiang Hisoar Pharmaceutical

Premium access

Detailed competitors of Zhejiang Hisoar Pharmaceutical

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Zhejiang Hisoar Pharmaceutical

Premium access

Complete news archive for Zhejiang Hisoar Pharmaceutical

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Zhejiang Hisoar Pharmaceutical

Zhejiang Hisoar Pharmaceutical was founded in 1966.

Zhejiang Hisoar Pharmaceutical is headquartered in Taizhou, China. It is registered at Taizhou, Jiangsu, China.

As of Dec 31, 2024, the latest employee count at Zhejiang Hisoar Pharmaceutical is 2,610.

Annual revenue of Zhejiang Hisoar Pharmaceutical is $261.67M as on Dec 31, 2024.

Founded in 1966, Zhejiang Hisoar Pharmaceutical is based in Taizhou, China. Operations focus on the production of speciality raw materials, fine chemicals, and dyes along with dye intermediates within the chemical and pharmaceutical sectors. Manufacturing activities are conducted to support industrial applications, with emphasis placed on quality standards and supply chain efficiency in the domestic market.

Yes, Zhejiang Hisoar Pharmaceutical is publicly traded on SZSE under the ticker symbol 002099.

The ticker symbol of Zhejiang Hisoar Pharmaceutical is 002099 on SZSE.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available